Skip to main content
. 2017 Oct 17;8(61):103919–103930. doi: 10.18632/oncotarget.21865

Figure 4. MiR-590-3P inhibits proliferation of HCC cells.

Figure 4

(A) Growth of HepG2 cells was shown after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (B) growth of MHCC97H cells was shown after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (C) cell cycle analysis of HepG2 cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; (D) cell cycle analysis of MHCC97H cells after transfection with miR-590-3P mimics, EED siRNA, miR-590-3P inhibitors or controls; the growth index as assessed at 0, 24, 48 and 72 h; *p<0.05, **p<0.01, and ***p<0.001.